{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:33:21Z","timestamp":1792215201897,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00066-022-01985-4","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T07:02:39Z","timestamp":1660028559000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hypofractionated radiotherapy after breast-conserving surgery: Clinical and dosimetric factors predictive of acute skin toxicity"],"prefix":"10.1007","volume":"199","author":[{"given":"Raouia","family":"Ben Amor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Bohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeineb","family":"Naimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorra","family":"Aissaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Mejri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamel","family":"Yahyaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awatef","family":"Hamdoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotfi","family":"Kochbati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"issue":"9935","key":"1985_CR1","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"EBCTCG (Early Breast Cancer Trialists\u2019 Collaborative Group), McGale\u00a0P, Taylor\u00a0C, Correa\u00a0C, Cutter\u00a0D, Duane\u00a0F et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135\u00a0women in 22 randomised trials. Lancet 383(9935):2127\u20132135","journal-title":"Lancet"},{"issue":"9618","key":"1985_CR2","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","volume":"371","author":"SM Bentzen","year":"2008","unstructured":"START Trialists\u2019 Group, Bentzen\u00a0SM, Agrawal\u00a0RK, Aird\u00a0EGA, Barrett\u00a0JM, Barrett-Lee\u00a0PJ et al (2008) The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a\u00a0randomised trial. Lancet 371(9618):1098\u20131107","journal-title":"Lancet"},{"issue":"4","key":"1985_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.semradonc.2008.04.008","volume":"18","author":"TJ Whelan","year":"2008","unstructured":"Whelan\u00a0TJ, Kim\u00a0D\u2011H, Sussman\u00a0J (2008) Clinical experience using hypofractionated radiation schedules in breast cancer. Semin Radiat Oncol 18(4):257\u2013264","journal-title":"Semin Radiat Oncol"},{"issue":"7","key":"1985_CR4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jamaoncol.2015.2666","volume":"1","author":"SF Shaitelman","year":"2015","unstructured":"Shaitelman\u00a0SF, Schlembach\u00a0PJ, Arzu\u00a0I, et\u00a0al (2015) Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: A\u00a0randomized clinical trial. JAMA Oncol 1(7):931\u2013941. https:\/\/doi.org\/10.1001\/jamaoncol.2015.2666","journal-title":"JAMA Oncol"},{"issue":"10237","key":"1985_CR5","doi-asserted-by":"publisher","first-page":"30932","DOI":"10.1016\/S0140-6736","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"Murray Brunt\u00a0A, Haviland\u00a0JS, Wheatley\u00a0DA, et\u00a0al (2020) Hypofractionated breast radiotherapy for 1\u00a0week versus 3\u00a0weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a\u00a0multicentre, non-inferiority, randomised, phase\u00a03 trial. Lancet 395(10237):1613\u20131626. https:\/\/doi.org\/10.1016\/S0140-6736(20)30932-6","journal-title":"Lancet"},{"key":"1985_CR6","unstructured":"CTEP Common terminology criteria for adverse events (CTCAE) | protocol development. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm. Accessed 12.2021"},{"issue":"1","key":"1985_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","volume":"114","author":"BV Offersen","year":"2015","unstructured":"Offersen\u00a0BV, Boersma\u00a0LJ, Kirkove\u00a0C, Hol\u00a0S, Aznar\u00a0MC, Biete Sola\u00a0A et\u00a0al (2015) ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol 114(1):3\u201310","journal-title":"Radiother Oncol"},{"issue":"4","key":"1985_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12094-016-1548-3","volume":"19","author":"J Sanz","year":"2017","unstructured":"Sanz\u00a0J, Rodr\u00edguez\u00a0N, Foro\u00a0P, et\u00a0al (2017) Hypofractionated boost after whole breast irradiation in breast carcinoma: chronic toxicity results and cosmesis. Clin Transl Oncol 19(4):464\u2013469. https:\/\/doi.org\/10.1007\/s12094-016-1548-3","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"1985_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1471-2407-13-230","volume":"13","author":"G Tortorelli","year":"2013","unstructured":"Tortorelli\u00a0G, Di Murro\u00a0L, Barbarino\u00a0R, Cicchetti\u00a0S, di Cristino\u00a0D, Falco\u00a0MD et\u00a0al (2013) Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a\u00a0retrospective analysis of acute skin toxicity and dose inhomogeneities. Bmc Cancer 13(1):230. https:\/\/doi.org\/10.1186\/1471-2407-13-230","journal-title":"Bmc Cancer"},{"issue":"1","key":"1985_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.radonc.2016.02.027","volume":"120","author":"AM Brunt","year":"2016","unstructured":"Brunt\u00a0AM, Wheatley\u00a0D, Yarnold\u00a0J, Somaiah\u00a0N, Kelly\u00a0S, Harnett\u00a0A et al (2016) Acute skin toxicity associated with a\u00a01-week schedule of whole breast radiotherapy compared with a\u00a0standard 3\u2011week regimen delivered in the UK FAST-Forward Trial. Radiother Oncol 120(1):114\u2013118","journal-title":"Radiother Oncol"},{"key":"1985_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003860.pub4","author":"BE Hickey","year":"2016","unstructured":"Hickey\u00a0BE, James\u00a0ML, Lehman\u00a0M, Hider\u00a0PN, Jeffery\u00a0M, Francis\u00a0DP et\u00a0al (2016) Fraction size in radiation therapy for breast conservation in early breast cancer. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD003860.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1985_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/jjco\/hyy160","volume":"49","author":"M Nozaki","year":"2019","unstructured":"Nozaki\u00a0M, Kagami\u00a0Y, Shibata\u00a0T, Nakamura\u00a0K, Ito\u00a0Y, Nishimura\u00a0Y et al (2019) A primary analysis of a\u00a0multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906. Jpn J Clin Oncol 49(1):57\u201362. https:\/\/doi.org\/10.1093\/jjco\/hyy160","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"1985_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","volume":"75","author":"J Yarnold","year":"2005","unstructured":"Yarnold\u00a0J, Ashton\u00a0A, Bliss\u00a0J, Homewood\u00a0J, Harper\u00a0C, Hanson\u00a0J et al (2005) Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a\u00a0randomised trial. Radiother Oncol 75(1):9\u201317","journal-title":"Radiother Oncol"},{"issue":"3","key":"1985_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.breast.2010.03.002","volume":"19","author":"CL Holloway","year":"2010","unstructured":"Holloway\u00a0CL, Panet-Raymond\u00a0V, Olivotto\u00a0I (2010) Hypofractionation should be the new \u2018standard\u2019 for radiation therapy after breast conserving surgery. Breast 19(3):163\u2013167","journal-title":"Breast"},{"issue":"1","key":"1985_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijrobp.2011.05.074","volume":"83","author":"PL Dorn","year":"2012","unstructured":"Dorn\u00a0PL, Corbin\u00a0KS, Al-Hallaq\u00a0H, Hasan\u00a0Y, Chmura\u00a0SJ (2012) Feasibility and acute toxicity of Hypofractionated radiation in large-breasted patients. Int J Radiat Oncol Biol Phys 83(1):79\u201383","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1985_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1748-717X-9-97","volume":"9","author":"P Ciammella","year":"2014","unstructured":"Ciammella\u00a0P, Podgornii\u00a0A, Galeandro\u00a0M, Micera\u00a0R, Ramundo\u00a0D, Palmieri\u00a0T et al (2014) Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors. Radiat Oncol 9(1):97. https:\/\/doi.org\/10.1186\/1748-717X-9-97","journal-title":"Radiat Oncol"},{"issue":"5","key":"1985_CR17","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.ijrobp.2007.02.044","volume":"68","author":"A Harsolia","year":"2007","unstructured":"Harsolia\u00a0A, Kestin\u00a0L, Grills\u00a0I, Wallace\u00a0M, Jolly\u00a0S, Jones\u00a0C et al (2007) Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 68(5):1375\u20131380","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1985_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3747\/co.v17i5.604","volume":"17","author":"T Hijal","year":"2010","unstructured":"Hijal\u00a0T, Al Hamad\u00a0AA, Niazi\u00a0T, Sultanem\u00a0K, Bahoric\u00a0B, Vuong\u00a0T et al (2010) Hypofractionated radiotherapy and adjuvant chemotherapy do not increase radiation-induced dermatitis in breast cancer patients. Curr Oncol 17(5):22\u201327","journal-title":"Curr Oncol"},{"issue":"11","key":"1985_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.12998\/wjcc.v2.i11.705","volume":"2","author":"V Kouloulias","year":"2014","unstructured":"Kouloulias\u00a0V, Zygogianni\u00a0A, Kypraiou\u00a0E, Georgakopoulos\u00a0J, Thrapsanioti\u00a0Z, Beli\u00a0I et\u00a0al (2014) Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancer. WJCC 2(11):705\u2013710","journal-title":"WJCC"},{"issue":"1","key":"1985_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/tbj.12206","volume":"20","author":"A Zygogianni","year":"2014","unstructured":"Zygogianni\u00a0A, Kouloulias\u00a0V, Antypas\u00a0C, Armpilia\u00a0C, Kyrgias\u00a0G, Kouvaris\u00a0J (2014) The impact of intermediate time between chemotherapy and hypofractionated radiotherapy to the radiation induced skin toxicity for breast adjuvant treatment. Breast\u00a0J 20(1):74\u201378. https:\/\/doi.org\/10.1111\/tbj.12206","journal-title":"Breast J"},{"issue":"1","key":"1985_CR21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1186\/1471-2407-14-711","volume":"14","author":"S De Langhe","year":"2014","unstructured":"De Langhe\u00a0S, Mulliez\u00a0T, Veldeman\u00a0L, Remouchamps\u00a0V, van Greveling\u00a0A, Gilsoul\u00a0M et al (2014) Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy. Bmc Cancer 14(1):711. https:\/\/doi.org\/10.1186\/1471-2407-14-711","journal-title":"Bmc Cancer"},{"issue":"3","key":"1985_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S1470-2045(10)70013-9","volume":"11","author":"D Azria","year":"2010","unstructured":"Azria\u00a0D, Belkacemi\u00a0Y, Romieu\u00a0G, Gourgou\u00a0S, Gutowski\u00a0M, Zaman\u00a0K et al (2010) Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a\u00a0phase 2 randomised trial. Lancet Oncol 11(3):258\u2013265","journal-title":"Lancet Oncol"},{"issue":"1","key":"1985_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.meddos.2018.01.004","volume":"44","author":"LG Keenan","year":"2019","unstructured":"Keenan\u00a0LG, Lavan\u00a0N, Dunne\u00a0M, McArdle\u00a0O (2019) Modifiable risk factors for acute skin toxicity in adjuvant breast radiotherapy: dosimetric analysis and review of the literature. Med Dosim 44(1):51\u201355","journal-title":"Med Dosim"},{"issue":"3","key":"1985_CR24","first-page":"178","volume":"16","author":"AN Taher","year":"2004","unstructured":"Taher\u00a0AN, El-Baradie\u00a0MM, Essa\u00a0H, Zaki\u00a0O, Ezzat\u00a0S (2004) Hypofractionation versus conventional fractionation radiotherapy after conservative treatment of breast cancer: early skin reactions and cosmetic results. J Egypt Natl Canc Inst 16(3):178\u2013187","journal-title":"J Egypt Natl Canc Inst"},{"key":"1985_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.breast.2016.07.013","volume":"29","author":"MC De Santis","year":"2016","unstructured":"De Santis\u00a0MC, Bonfantini\u00a0F, Di Salvo\u00a0F, Dispinzieri\u00a0M, Mantero\u00a0E, Soncini\u00a0F et\u00a0al (2016) Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy. Breast 29:90\u201395","journal-title":"Breast"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-01985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-022-01985-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-01985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T16:18:49Z","timestamp":1673626729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-022-01985-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1985"],"URL":"https:\/\/doi.org\/10.1007\/s00066-022-01985-4","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"6 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"R.\u00a0Ben Amor, M.\u00a0Bohli, Z.\u00a0Naimi, D.\u00a0Aissaoui, N.\u00a0Mejri, J.\u00a0Yahyaoui, A.\u00a0Hamdoun, and L.\u00a0Kochbati certify that they have no affiliations with or involvement in any organization or entity with any financial interest or nonfinancial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study has been approved by the institution\u2019s ethics committee. <i>Consent to participate<\/i>: Informed consent was obtained from all individual participants included in the study. <i>Consent to publish<\/i>: Patients signed informed consent regarding publishing their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}